Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

15.42
Delayed Data
As of Sep 20
 +0.22 / +1.45%
Today’s Change
12.48
Today|||52-Week Range
19.94
+0.85%
Year-to-Date
No recent news for Ironwood Pharmaceuticals Inc.

Today’s Trading

Previous close15.20
Today’s open15.31
Day’s range15.19 - 15.57
Volume1,017,986
Average volume (3 months)1,176,695
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)+44.00%
Earnings growth (this year)-101.52%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+83.18%
P/E ratioNM
Price/Sales8.09
Price/Book33.52

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+0.64+0.99%
RAREUltragenyx Pharmaceu...+0.73+1.41%
SUPNSupernus Pharmaceuti...-1.30-3.42%
FOLDAmicus Therapeutics ...+0.96+6.88%
Data as of 3:59pm ET, 09/20/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$274.0M
Annual profit (last year)-$81.7M
Net profit margin-29.83%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Peter M. Hecht
CFO, CAO, Controller &
VP-Finance
Gina R. Consylman
Corporate headquarters
Cambridge, Massachusetts

Forecasts